Literature DB >> 20232099

A second MNGIE patient without typical mitochondrial skeletal muscle involvement.

Elena Cardaioli1, Paola Da Pozzo, Edoardo Malfatti, Carla Battisti, Gian Nicola Gallus, Carmen Gaudiano, Marco Macucci, Alessandro Malandrini, Maria Margollicci, Anna Rubegni, Maria Teresa Dotti, Antonio Federico.   

Abstract

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is an autosomal recessive disease caused by mutations in the gene encoding thymidine phosphorylase (TYMP). Clinically, MNGIE is characterized by gastrointestinal dysmotility, cachexia, ptosis, ophthalmoparesis, peripheral neuropathy and leukoencephalopathy. Most MNGIE patients have signs of mitochondrial dysfunction in skeletal muscle at morphological and enzyme level, as well as mitochondrial DNA depletion, multiple deletions and point mutations. A case without mitochondrial skeletal muscle involvement and with a TYMP splice-acceptor site mutation (c. 215-1 G>C) has been reported. Here, we describe an Italian patient with the same mutation and without mitochondrial skeletal muscle involvement, suggesting a possible genotype-phenotype correlation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20232099     DOI: 10.1007/s10072-010-0225-5

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  12 in total

Review 1.  Digestive smooth muscle mitochondrial myopathy in patients with mitochondrial-neuro-gastro-intestinal encephalomyopathy (MNGIE).

Authors:  Hugues Blondon; Marc Polivka; Francisca Joly; Bernard Flourie; Jacqueline Mikol; Bernard Messing
Journal:  Gastroenterol Clin Biol       Date:  2005 Aug-Sep

2.  Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations.

Authors:  I Nishino; A Spinazzola; A Papadimitriou; S Hammans; I Steiner; C D Hahn; A M Connolly; A Verloes; J Guimarães; I Maillard; H Hamano; M A Donati; C E Semrad; J A Russell; A L Andreu; G M Hadjigeorgiou; T H Vu; S Tadesse; T G Nygaard; I Nonaka; I Hirano; E Bonilla; L P Rowland; S DiMauro; M Hirano
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

3.  Thymidine phosphorylase gene mutations in patients with mitochondrial neurogastrointestinal encephalomyopathy syndrome.

Authors:  A Slama; C Lacroix; V Plante-Bordeneuve; A Lombès; M Conti; J M Reimund; E Auxenfants; P Crenn; P Laforêt; A Joannard; D Seguy; H Pillant; P Joly; S Haut; B Messing; G Said; A Legrand; A Guiochon-Mantel
Journal:  Mol Genet Metab       Date:  2005-01-24       Impact factor: 4.797

4.  Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder.

Authors:  M Hirano; G Silvestri; D M Blake; A Lombes; C Minetti; E Bonilla; A P Hays; R E Lovelace; I Butler; T E Bertorini
Journal:  Neurology       Date:  1994-04       Impact factor: 9.910

Review 5.  Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a disease of two genomes.

Authors:  Michio Hirano; Yutaka Nishigaki; Ramon Martí
Journal:  Neurologist       Date:  2004-01       Impact factor: 1.398

Review 6.  [MNGIE syndrome in 2 siblings].

Authors:  M Debouverie; M Wagner; X Ducrocq; Y Grignon; B Mousson; M Weber
Journal:  Rev Neurol (Paris)       Date:  1997-10       Impact factor: 2.607

7.  MNGIE with lack of skeletal muscle involvement and a novel TP splice site mutation.

Authors:  K Szigeti; L-J C Wong; C-L Perng; G M Saifi; K Eldin; A M Adesina; D L Cass; M Hirano; J R Lupski; F Scaglia
Journal:  J Med Genet       Date:  2004-02       Impact factor: 6.318

8.  Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes and tumors.

Authors:  A Yoshimura; Y Kuwazuru; T Furukawa; H Yoshida; K Yamada; S Akiyama
Journal:  Biochim Biophys Acta       Date:  1990-04-23

Review 9.  Metabolic myopathies: update 2009.

Authors:  Brian A van Adel; Mark A Tarnopolsky
Journal:  J Clin Neuromuscul Dis       Date:  2009-03

10.  Thymidine and deoxyuridine accumulate in tissues of patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE).

Authors:  Maria Lucia Valentino; Ramon Martí; Saba Tadesse; Luis Carlos López; Jose L Manes; Judy Lyzak; Angelika Hahn; Valerio Carelli; Michio Hirano
Journal:  FEBS Lett       Date:  2007-06-27       Impact factor: 4.124

View more
  10 in total

Review 1.  CoQ(10) deficiencies and MNGIE: two treatable mitochondrial disorders.

Authors:  Michio Hirano; Caterina Garone; Catarina M Quinzii
Journal:  Biochim Biophys Acta       Date:  2012-01-18

2.  A new thymidine phosphorylase mutation causing elongation of the protein underlies mitochondrial neurogastrointestinal encephalomyopathy.

Authors:  Elena Cardaioli; Francesco Sicurelli; Maria Alessandra Carluccio; Gian Nicola Gallus; Paola Da Pozzo; Mauro Mondelli; Maria Antonietta Margollicci; Vanna Micheli; Antonio Federico; Maria Teresa Dotti
Journal:  J Neurol       Date:  2011-06-12       Impact factor: 4.849

3.  Mitochondrial Neurogastrointestinal Encephalomyopathy Disease in Three Siblings from Pakistan with a Novel Mutation.

Authors:  Sana Durrani; Bee Chin Chen; Yusnita Yakob; Lua Seok Hian; Bushra Afroze
Journal:  J Pediatr Genet       Date:  2018-06-30

4.  Pitfalls in diagnosing mitochondrial neurogastrointestinal encephalomyopathy.

Authors:  Massimiliano Filosto; Mauro Scarpelli; Paola Tonin; Silvia Testi; Maria Sofia Cotelli; Mara Rossi; Andrea Salvi; Alberto Grottolo; Valentina Vielmi; Alice Todeschini; Gian Maria Fabrizi; Alessandro Padovani; Giuliano Tomelleri
Journal:  J Inherit Metab Dis       Date:  2011-04-19       Impact factor: 4.982

Review 5.  Mitochondrial Neurogastrointestinal Encephalomyopathy Caused by Thymidine Phosphorylase Enzyme Deficiency: From Pathogenesis to Emerging Therapeutic Options.

Authors:  Rana Yadak; Peter Sillevis Smitt; Marike W van Gisbergen; Niek P van Til; Irenaeus F M de Coo
Journal:  Front Cell Neurosci       Date:  2017-02-15       Impact factor: 5.505

6.  Clinical and molecular characterization of a patient with mitochondrial Neurogastrointestinal Encephalomyopathy.

Authors:  Parham Habibzadeh; Mohammad Silawi; Hassan Dastsooz; Shima Bahramjahan; Shahrokh Ezzatzadegan Jahromi; Vahid Reza Ostovan; Majid Yavarian; Mohammad Mofatteh; Mohammad Ali Faghihi
Journal:  BMC Gastroenterol       Date:  2020-05-08       Impact factor: 3.067

Review 7.  Mitochondrial Neurogastrointestinal Encephalomyopathy: Into the Fourth Decade, What We Have Learned So Far.

Authors:  Dario Pacitti; Michelle Levene; Caterina Garone; Niranjanan Nirmalananthan; Bridget E Bax
Journal:  Front Genet       Date:  2018-12-21       Impact factor: 4.599

8.  Mitochondrial multiorgan disorder syndrome score generated from definite mitochondrial disorders.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Neuropsychiatr Dis Treat       Date:  2017-10-06       Impact factor: 2.570

Review 9.  Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE-MTDPS1).

Authors:  Massimiliano Filosto; Stefano Cotti Piccinelli; Filomena Caria; Serena Gallo Cassarino; Enrico Baldelli; Anna Galvagni; Irene Volonghi; Mauro Scarpelli; Alessandro Padovani
Journal:  J Clin Med       Date:  2018-10-26       Impact factor: 4.241

10.  Mitochondrial neurogastrointestinal encephalomyopathy: approaches to diagnosis and treatment.

Authors:  Bridget E Bax
Journal:  J Transl Genet Genom       Date:  2020-03-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.